Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Product sales, net $ 13,789 $ 15,705
Revenue, Product and Service [Extensible Enumeration] us-gaap:ProductMember us-gaap:ProductMember
Cost of goods sold $ 7,037 $ 8,537
Gross profit 6,752 7,168
Operating expenses:    
Research and development 122 118
Selling, general and administrative 7,622 9,240
Benefit from reversal of accrued payroll taxes (Note 12) (522) 0
Total operating expenses 7,222 9,358
Operating loss (470) (2,190)
Gain on extinguishment of debt (38) 0
Interest expense, net 517 212
Loss before income taxes (949) (2,402)
Income tax expense (benefit) 9 (8)
Net loss $ (958) $ (2,394)
Weighted average common shares outstanding, basic (in shares) 184,264 175,585
Weighted average common shares outstanding, diluted (in shares) 184,264 175,585
Net loss per common share, basic (in USD per share) $ (0.01) $ (0.01)
Net loss per common share, basic diluted (in USD per share) $ (0.01) $ (0.01)